MedTrace Logo

Training "Pain Connoisseurs" for Efficient Analgesic Proof-of-Concept Studies

NCT02842554 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2016-07-25

No results posted yet for this study

Summary

The purpose of this study is to assess the ability of Evoked Pain Training (EPT) and Drug/ Placebo Administration (DPA) training to increase subjects' ability to discriminate between active and placebo treatments in a double-blind crossover trial of a known analgesic, measured by standardized effect size, relative to untrained control subjects.

Conditions

  • Painful Diabetic Neuropathy (PDN)

Interventions

OTHER

EPT

DRUG

Drug Placebo Administration

OTHER

C

No Intervention

Sponsors & Collaborators

  • Grünenthal GmbH

    collaborator INDUSTRY

  • Analgesic Solutions

    lead INDUSTRY

Principal Investigators

  • Stephen Wright, MD · Analgesic Solutions

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02842554 on ClinicalTrials.gov